[{"path":"/safety/recalls-market-withdrawals-safety-alerts/pacifico-national-inc-dba-amex-pharmacy-issues-voluntary-nationwide-recall-all-lots-bevacizumab","field_change_date_2":"08/30/2019","field_brand_name":"<a href=\"/safety/recalls-market-withdrawals-safety-alerts/pacifico-national-inc-dba-amex-pharmacy-issues-voluntary-nationwide-recall-all-lots-bevacizumab\">AmEx Pharmacy</a>","field_product_description":"Bevacizumab 1.25mg/0.05mL 31G Injectable and Bevacizumab 2.5mg/0.1ml Normject TB Injectable","field_recall_reason_description":"Potential for non-sterility","field_recall_reason":"Device &amp; Drug Safety","field_company_name":"Pacifico National, Inc. dba AmEx Pharmacy","term_node_tid":"","field_regulated_product_field":"Drugs","all-terms-rewrite":"Drugs, ","publicationDate":"2019-08-30T04:00:00.000Z","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pacifico-national-inc-dba-amex-pharmacy-issues-voluntary-nationwide-recall-all-lots-bevacizumab","canonicalId":"d665c048bc7348743c35513f8a761032794acd46e09848c273fcd1a6aae5b7aa","title":"Pacifico National, Inc. dba AmEx Pharmacy Issues Voluntary Nationwide Recall for all Lots of Bevacizumab","description":"AmEx Pharmacy today announces a voluntary recall of all Lots of Bevacizumab 1.25mg/0.05mL 31G Injectable and all Lots of Bevacizumab 2.5mg/0.1ml Normject TB Injectable that are within expiry to the healthcare provider level. These lots are being recalled out of an abundance of caution following an F","feedName":"fda","feedSource":"fda","categories":[]}]